Trent Hall
310 Trent Drive
Durham, NC 27708
United States
Duke Global Health Institute
COVID-19, pandemic, vaccine, infectious diseases, research and development, clinical trials
poverty-related and neglected diseases (PRNDs), aggregator mechanism, research and development, clinical trials, antimicrobial resistance, infectious diseases, Covid-19, AIDS, tuberculosis, malaria, public funding for R&D, vaccine, public health
transition, graduation, aid, official development assistance
Transition, graduation, foreign aid, health aid, development assistance for health, aid for health, multilateral donor, bilateral donor, the World Bank, USAID, PEPFAR, DFID, JICA
Global Public Goods, International Collective Action for Health, Global Action Plan, Aid for Health, World Health Organization, World Bank Group, Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis, and Malaria
health financing, universal health coverage, insurance, PM-JAY, India
Aid for health, health aid, development assistance for health, official development assistance, transition, transition readiness, transition assessment, transition framework, transition tool, graduation, self-reliance, donor exit
beyond GDP, well-being, health, inequality, human development, lifetime income
Grand Convergence; Equity; Pro-poor Universal Health Coverage; Domestic Financing of Health; Population; Policy; and Implementation Research; Intersectoral Collaboration; Global Health; Aid Effectiveness
Development assistance for health, health aid, multilateral donor, bilateral donor, Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Bank, USAID, PEPFAR, Japan, transition from aid, aid targeting, pockets of poverty, Sustainable Development Goals (SDGs)
